Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Pulmonary complications of novel antineoplastic agents for solid tumors Vahid B; Marik PEChest 2008[Feb]; 133 (2): 528-38Antineoplastic agent-induced pulmonary toxicity is an important cause of respiratory failure. Although the incidence of antineoplastic agent-induced pulmonary toxicity seems to be low, more cases can be expected, with increasing numbers of patients receiving the new generations of antineoplastic agents. Antineoplastic agents have previously been associated with bronchospasm, hypersensitivity reactions, venous thromboembolism, and pulmonary hemorrhage. Physicians should be aware of the clinical and radiographic presentations of the pulmonary toxicities associated with the newer antineoplastic agents. The approach to diagnosis, risk factors, and possible mechanisms of antineoplastic agent-induced pulmonary toxicity are discussed in this article.|Antibiotics, Antineoplastic/adverse effects[MESH]|Antibodies, Monoclonal, Humanized[MESH]|Antibodies, Monoclonal/adverse effects[MESH]|Antimetabolites, Antineoplastic/adverse effects[MESH]|Antineoplastic Agents/*adverse effects/therapeutic use[MESH]|Bevacizumab[MESH]|Deoxycytidine/adverse effects/analogs & derivatives[MESH]|Doxorubicin/adverse effects[MESH]|Epirubicin/adverse effects[MESH]|Etoposide/adverse effects[MESH]|Everolimus[MESH]|Gemcitabine[MESH]|Humans[MESH]|Lung Diseases/*chemically induced[MESH]|Lung/drug effects[MESH]|Mitoxantrone/adverse effects[MESH]|Neoplasms/drug therapy[MESH]|Pneumonia/chemically induced/physiopathology[MESH]|Pyrimidines/adverse effects[MESH]|Risk Factors[MESH]|Sirolimus/adverse effects/analogs & derivatives[MESH]|Teniposide/adverse effects[MESH]|Trastuzumab[MESH] |
